Zymeworks Inc

ZYMEStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$25.93

Today

+2.1%

YTD

-1.4%

About

Zymeworks, Inc. is a global biotechnology company focusing on the discovery, development, and commercialisation of next-generation multifunctional therapies. These therapies are created for prevalent and life-threatening diseases including cancer. Operating in the biotechnology industry, Zymeworks engineers and develops antibody-based therapeutic treatments. The company’s novel therapies are marked by its proprietary complementary therapeutic platforms. Zymeworks has partnerships with multiple companies including BeiGene, ALX Oncology, LEO Pharma, and more. Keep up to date on the latest share price changes by adding ZYME stock to your eToro watchlist.

Price chart

Closing price history for ZYME (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-13.01

P/S (TTM)51.53

P/B (TTM)23.47

Market cap$1.87B

Cap tierSmall-cap

Industry avg P/E-7.42

Profitability

Gross margin75.55%

EBIT margin-418.99%

Net margin-980.81%

ROE-72.31%

ROA-37.25%

Earnings & Revenue

Revenue (TTM)$37.13M

Revenue growth (1Y)-69.8%

EPS (TTM)-$2.01

Free cash flow$-120.40M

Total debt$268.64M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.92

Employees264

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.